WAVE Life Sciences Ltd (STU:1U5)
€ 7.5 0.25 (3.45%) Market Cap: 1.17 Bil Enterprise Value: 1.05 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

Q2 2024 WAVE Life Sciences Ltd Earnings Call Transcript

Aug 08, 2024 / 12:30PM GMT
Release Date Price: €5.4
Operator

Good morning, and welcome to the Wave Life Sciences second quarter 2024 financial results conference call. (Operator Instructions) As a reminder, this call is being recorded and webcast. I'll now turn the call over to Kate Rausch, Vice President, Investor Relations and Corporate Affairs. Please go ahead.

Kate Rausch
WAVE Life Sciences Ltd - Investor Relations

Thank you, operator. Good morning, and thank you for joining us today to discuss our recent business progress and review Wave's second quarter 2024 financial results. Joining me today with prepared remarks are Dr. Paul Bolno, President and Chief Executive Officer; Anne-Marie Li-Kwai-Cheung, Chief Development Officer; and Kyle Moran, Chief Financial Officer. Erik Ingelsson, Chief Scientific Officer; Chandra Vargeese, Chief Technology Officer; and Ginnie Yang, SVP of Translational Medicine, will also be available for questions following the call.

The press release issued this morning is available on the Investors section of our website,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot